Advagene Biopharma Co Ltd banner
A

Advagene Biopharma Co Ltd
TPEX:6709

Watchlist Manager
Advagene Biopharma Co Ltd
TPEX:6709
Watchlist
Price: 24.55 TWD 2.29%
Market Cap: NT$1.7B

Bankruptcy Probability

Advagene Biopharma Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .

We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.

Probability of Bankruptcy
LOCKED
Unlock

Financial Position

Cash & Short-Term Investments
+
3Y
+31%
5Y
-51%
10Y
-
Long-Term Investments
+
3Y
-
5Y
-
10Y
-
Debt
+
3Y
+306%
5Y
-40%
10Y
-

Solvency Ratios

Solvency Ratios Comparison
Advagene Biopharma Co Ltd Competitors

Country Company Market Cap D/E D/A Interest
Coverage
Altman
Z-Score
Quick
Ratio
Current
Ratio
Cash
Ratio
TW
Advagene Biopharma Co Ltd
TPEX:6709
1.7B TWD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1.1T USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
616.6B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
356.2B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
OTC:RHHBF
334.6B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.1B CHF
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
182.5B GBP
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CA
Nuvo Pharmaceuticals Inc
TSX:MRV
322B CAD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
158.4B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.9B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found
Is Advagene Biopharma Co Ltd at risk of bankruptcy?

Advagene Biopharma Co Ltd's probability of bankruptcy is Hidden .

The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Advagene Biopharma Co Ltd have?

As of the latest report, Advagene Biopharma Co Ltd has total debt of 2.6m TWD. This includes both short-term (0 TWD) and long-term (2.6m TWD) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top